Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Sci Rep ; 13(1): 17171, 2023 10 11.
Article in English | MEDLINE | ID: mdl-37821520

ABSTRACT

Although a decrease in stroke admissions during the SARS-CoV-2 pandemic has been observed, detailed analyses of the evolution of stroke metrics during the pandemic are lacking. We analyzed changes in stroke presentation, in-hospital systems-of-care, and treatment time metrics at two representative Comprehensive Stroke Centers (CSCs) during the first year of Coronavirus disease 2019 pandemic. From January 2018 to May 2021, data from stroke presentations to two CSCs were obtained. The study duration was split into: period 0 (prepandemic), period 1 (Wave 1), period 2 (Lull), and period 3 (Wave 2). Acute stroke therapies rates and workflow times were compared among pandemic and prepandemic periods. Analyses were adjusted for age, sex, comorbidities, and pre-morbid care needs. There was a significant decrease in monthly hospital presentations of stroke during Wave 1. Both centers reported declines in reperfusion therapies during Wave 1, slowly catching up but never to pre pandemic numbers, and dropping again in Wave 2. Both CSCs experienced in-hospital workflow delays during Waves 1 and 2, and even during the Lull period. Our results highlight the need for proactive strategies to reduce barriers to workflow and hospital avoidance for stroke patients during crisis periods.


Subject(s)
COVID-19 , Stroke , Humans , COVID-19/epidemiology , SARS-CoV-2 , Pandemics , Stroke/epidemiology , Stroke/therapy , Comorbidity , Retrospective Studies
2.
Stroke ; 54(2): 345-353, 2023 02.
Article in English | MEDLINE | ID: mdl-36689580

ABSTRACT

BACKGROUND: Ischemic stroke (IS) is a leading cause of long-term disability with sex-specific differences in outcomes. Identifying the influential factors that contribute to sex-specific disparities in stroke outcomes, therefore, holds potential to develop individualized interventions for reducing long-term disability. Further, investigating the association between sex and Patient-Reported Outcome Measures (PROMs) provides additional information on the individual impact and heterogeneity of IS. We aimed to identify sex-specific differences in stroke outcomes and relationship with PROMs in IS patients with 3-month follow-up. METHODS: Between February 2017 and February 2020, a total of 410 patients admitted with IS to the Massachusetts General Hospital, in Boston, were enrolled in this prospective cohort. At 3-month poststroke, patients were assessed for Barthel Index, modified Rankin Scale, and PROM-10 questionnaires. T scores for physical and mental health were determined from the summing of PROM-10 responses in each domain. Regression analysis was performed to identify sex-specific determinants of functional and patient-reported outcomes. RESULTS: At baseline, 242 participants were male (mean age, 65 years) and 168 were female (mean age, 70 years). Groups had similar rates of cardiovascular risk factors, admission National Institutes of Health Stroke Scale, and discharge modified Rankin Scale. At follow-up, male participants were more likely to have better rates of T Physical and Barthel Index. In regression analysis, PROMs T Physical (odds ratio, 1.06; P=0.01), Barthel Index (odds ratio, 1.06; P=0.01), and modified Rankin Scale score of ≥2 (odds ratio, 2.60; P=0.01) were associated with female sex. Female sex was also associated with lower scores for PROMs Physical subcomponents and with patient-reported general health and emotional problems. CONCLUSIONS: Women have worse outcomes after ischemic stroke, including objective measures of functional disability and patient-reported outcomes. Incorporating PROMs into IS outcome measures may offer additional insight into sex-specific differences in stroke recovery and outcomes.


Subject(s)
Ischemic Stroke , Stroke , Humans , Male , Female , Aged , Prospective Studies , Patient Discharge , Treatment Outcome , Patient Reported Outcome Measures , Disability Evaluation
4.
Galicia clin ; 83(4): 58-59, oct.-dic. 2022. ilus
Article in English | IBECS | ID: ibc-214900

ABSTRACT

Wall-eyed bilateral internuclear ophthalmoplegia is a rare neuroophthalmological condition characterized by dissociated abducting nystagmus, a large angle exotropia in primary gaze and supranuclearvertical gaze palsy.The authors present the case of an 83-year-old man admitted to theinternal medicine ward with the diagnosis of cholangitis that suddenlystarts with complaints of diplopia. Based on the clinical findings andresults of the diagnostic workup, was established the diagnosis ofWall-eyed bilateral internuclear ophthalmoplegia syndrome. (AU)


La oftalmoplejía internuclear bilateral es una rara condición neuroftalmológica caracterizada por nistagmo en abducción disociado, unaexotropía de gran ángulo en la mirada primaria y parálisis supranuclear de la mirada vertical.Los autores presentan el caso de un hombre de 83 años que ingresaen el servicio de medicina interna con el diagnóstico de colangitisque se inicia repentinamente con quejas de diplopía. Con base en loshallazgos clínicos y los resultados del estudio diagnóstico, se estableció el diagnóstico de síndrome de oftalmoplejía internuclear bilateral(síndrome WEBINO). (AU)


Subject(s)
Humans , Male , Aged, 80 and over , Ocular Motility Disorders/diagnostic imaging , Ocular Motility Disorders/etiology , Aspartate Aminotransferases , Exotropia
5.
Cureus ; 14(2): e22653, 2022 Feb.
Article in English | MEDLINE | ID: mdl-35371715

ABSTRACT

BACKGROUND:  COVID-19 poses a significantly more serious threat to adults aged 65 and above, with a higher mortality rate. This study aims to describe the outcome of COVID-19 patients in the elderly and very elderly population admitted to a tertiary care Portuguese hospital. The authors defined the elderly population (65 to 79 years) and the very elderly population (≥ 80 years). METHODS:  We conducted a retrospective observational single center study in the internal medicine ward of a tertiary hospital from November 1, 2020 to January 31, 2021. All COVID-19 patients aged over 65 years were enrolled. RESULTS:  Of the 824 patients with SARS-CoV-2 infection, 586 (71%) were aged above 65 years. Of them, 61.7% were very elderly and 32.9% were elderly. The hospital recorded 53 (27.5%) deaths in the elderly group and 182 (46.3%) in the over-80 group. In the elderly population, only 32 patients had critical illness compared to the 79 in the very elderly group. In addition to respiratory complications, acute kidney failure and liver dysfunction were noted. In both groups, mortality was higher when there was acute kidney injury (AKI). With respect to treatment, dexamethasone and azithromycin did not show a statistically significant difference between the groups. The need for oxygen therapy over 4L/min, high-flow therapy, and mechanical invasive ventilation was related to higher mortality in both groups. CONCLUSION:  The very elderly group had a higher number of deaths compared to the elderly group due to multiple comorbidities. Respiratory failure was the most frequently occurring complication. Surprisingly, dexamethasone and azithromycin therapy did not show a statistically significant effect in both age groups despite their current widespread usage in COVID-19 treatment worldwide.

7.
Acta Med Port ; 31(6): 338-340, 2018 Jun 29.
Article in English | MEDLINE | ID: mdl-30020879

ABSTRACT

Posterior reversible encephalopathy syndrome is an encephalopathy that can be clinically characterized by headache, altered mental status and/or seizures. Neuroimaging demonstrates usually reversible bilateral subcortical vasogenic occipital-parietal edema. Exact pathophysiology remains unclear but is commonly associated with hypertension, renal failure, sepsis and use of immunosuppressive therapy. Its development in the setting of severe hypercalcemia is extremely rare. The authors report a case of posterior reversible encephalopathy syndrome in a normotensive patient with severe hypercalcemia as the only identifiable cause.


A síndrome de encefalopatia posterior reversível corresponde a uma encefalopatia que pode caracterizar-se clinicamente por cefaleia, alteração do estado de consciência e/ou crises epiléticas. A neuroimagem geralmente revela edema vasogénico subcortical bilateral occipito-parietal reversível. A fisiopatologia permanece por esclarecer mas frequentemente associa-se a hipertensão, insuficiência renal, sépsis e uso de terapêutica imunossupressora. O seu desenvolvimento no contexto de hipercalcémia severa é extremamente raro. Os autores apresentam um caso de síndrome de encefalopatia posterior reversível numa doente normotensa com hipercalcemia severa como etiologia mais provável.


Subject(s)
Hypercalcemia/complications , Posterior Leukoencephalopathy Syndrome/etiology , Aged , Female , Humans , Severity of Illness Index
9.
J Cutan Pathol ; 39(12): 1119-24, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23046157

ABSTRACT

Angioimmunoblastic T-cell lymphoma (AITL) is frequently associated with skin lesions, but epidermotropic cutaneous involvement has never been described. A 37-year-old man presented with erythematous and pruriginous plaques, clinically suggestive of mycosis fungoides, distributed all over the body, 3 weeks after the last line of a polychemotherapy, given for an AITL diagnosed 1 year earlier on a lymph node biopsy. Skin biopsy showed an epidermotropic CD4(+) T-cell lymphoma, so that a diagnosis of mycosis fungoides was first proposed. Further investigations showed that atypical lymphocytes strongly expressed CD10 and markers of follicular helper T cells (T(FH) ) including PD1, BCL-6 and CXCL13. The diagnosis of an unusual epidermotropic cutaneous localization of the AITL was finally made, supported by the presence of the same T-cell clone in the initial lymph node biopsy and the skin. We therefore recommend performing markers of T(FH) cells in patients with unusual epidermotropic cutaneous T-cell lymphomas, particularly if they have any clinical features suggestive of AITL.


Subject(s)
Immunoblastic Lymphadenopathy/diagnosis , Lymphoma, T-Cell, Peripheral/diagnosis , Mycosis Fungoides/diagnosis , Skin Neoplasms/diagnosis , Skin/pathology , Adult , Biomarkers, Tumor/metabolism , Clone Cells , Diagnosis, Differential , Humans , Immunoblastic Lymphadenopathy/metabolism , Lymph Nodes/pathology , Lymphoma, T-Cell, Peripheral/metabolism , Male , Neprilysin/metabolism , Recurrence , Skin/metabolism , Skin Neoplasms/metabolism , T-Lymphocytes, Helper-Inducer/metabolism , T-Lymphocytes, Helper-Inducer/pathology
10.
Mod Pathol ; 24(8): 1046-54, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21499229

ABSTRACT

Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma of the elderly was included as a provisional entity in the 2008 WHO lymphoma classification. Most reports of this disease come from Asia and little is known about it in other regions of the world, including Latin America. Therefore, in this study, 305 diffuse large B-cell lymphomas in patients above 50 years were analyzed, 136 from Mexico and 169 from Germany. EBV was detected by Epstein-Barr early RNA (EBER) in situ hybridization. Only cases with EBER+ in the majority of tumor cells were regarded as EBV+ diffuse large B-cell lymphoma. The prevalence of EBV+ diffuse large B-cell lymphoma in Mexican patients was found to be 7% (9 of 136), whereas only 2% (4 of 169) of the German cases were positive. The median age at diagnosis was 66 years in the Mexican cohort, as opposed to 77 years in the German group. The site of presentation was in both groups predominantly nodal in nine cases (70%) and extranodal in four cases (30%). Of the 13 EBV+ cases, 10 (77%) were classified as polymorphic and 3 (23%) as monomorphic type. The polymorphic cases showed a non-germinal center B-cell immunophenotype (CD10- MUM1+). Twelve cases (92%) were LMP1 positive and two (15%) expressed EBNA2. An interesting finding was the high frequency of EBV type B with the LMP1 30 bp deletion found in the Mexican cases (50%). Eight of the 11 evaluable cases were B-cell monoclonal by polymerase chain reaction. In summary, we found a similar prevalence of EBV+ diffuse large B-cell lymphoma of the elderly in a Mexican population compared with what has been reported in Asian countries, and in contrast to the low frequency in Western populations (1-3%). However, compared with the Asian series, the Mexican patients were younger at diagnosis, presented predominantly with nodal disease and rarely expressed EBNA2 protein.


Subject(s)
Epstein-Barr Virus Infections/epidemiology , Epstein-Barr Virus Infections/etiology , Lymphoma, Large B-Cell, Diffuse/epidemiology , Lymphoma, Large B-Cell, Diffuse/virology , Age of Onset , Aged , Epstein-Barr Virus Infections/pathology , Epstein-Barr Virus Nuclear Antigens/analysis , Epstein-Barr Virus Nuclear Antigens/biosynthesis , Female , Germany/epidemiology , Herpesvirus 4, Human/genetics , Humans , In Situ Hybridization , Lymphoma, Large B-Cell, Diffuse/pathology , Male , Mexico/epidemiology , Middle Aged , Polymerase Chain Reaction , Prevalence , Viral Matrix Proteins/analysis , Viral Matrix Proteins/biosynthesis , Viral Proteins/analysis , Viral Proteins/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...